{"count": 2, "results": [{"_id": "35996325", "pmid": 35996325, "title": "Metformin improves neurobehavioral impairments of streptozotocin-treated and western diet-fed mice: Beyond glucose-lowering effects.", "journal": "Fundam Clin Pharmacol", "authors": ["Delanogare E", "Bullich S", "Barbosa LADS", "Barros WM", "Braga SP", "Kraus SI", "Kasprowicz JN", "Dos Santos GJ", "Guiard BP", "Moreira ELG"], "date": "2023-02-01T00:00:00Z", "doi": "10.1111/fcp.12825", "meta_date_publication": "2023 Feb", "meta_volume": "37", "meta_issue": "1", "meta_pages": "94-106", "score": 50263.3, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ improves @<m>DISEASE_Neurobehavioral_Manifestations</m> @DISEASE_MESH:D019954 @@@neurobehavioral impairments@@@ of @CHEMICAL_Streptozocin @CHEMICAL_MESH:D013311 @@@streptozotocin@@@-treated and western diet-fed @SPECIES_10090 @@@mice@@@: Beyond @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@-lowering effects.", "citations": {"NLM": "Delanogare E, Bullich S, Barbosa LADS, Barros WM, Braga SP, Kraus SI, Kasprowicz JN, Dos Santos GJ, Guiard BP, Moreira ELG. Metformin improves neurobehavioral impairments of streptozotocin-treated and western diet-fed mice: Beyond glucose-lowering effects. Fundam Clin Pharmacol. 2023 Feb;37(1):94-106. PMID: 35996325", "BibTeX": "@article{35996325, title={Metformin improves neurobehavioral impairments of streptozotocin-treated and western diet-fed mice: Beyond glucose-lowering effects.}, author={Delanogare E and Bullich S and Barbosa LADS and Barros WM and Braga SP and Kraus SI and Kasprowicz JN and Dos Santos GJ and Guiard BP and Moreira ELG}, journal={Fundam Clin Pharmacol}, volume={37}, number={1}, pages={94-106}}"}}, {"_id": "33064168", "pmid": 33064168, "pmcid": "PMC7561705", "title": "Selenium nanoparticles and metformin ameliorate streptozotocin-instigated brain oxidative-inflammatory stress and neurobehavioral alterations in rats", "journal": "Naunyn Schmiedebergs Arch Pharmacol", "authors": ["Ebokaiwe AP", "Okori S", "Nwankwo JO", "Ejike CECC", "Osawe SO"], "date": "2021-04-01T00:00:00Z", "doi": "10.1007/s00210-020-02000-2", "meta_date_publication": "2021 Apr", "meta_volume": "394", "meta_issue": "4", "meta_pages": "591-602", "score": 50260.984, "text_hl": "@CHEMICAL_Selenium @CHEMICAL_MESH:D012643 @@@Selenium@@@ nanoparticles and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ ameliorate @CHEMICAL_Streptozocin @CHEMICAL_MESH:D013311 @@@streptozotocin@@@-instigated brain oxidative-@DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ stress and @<m>DISEASE_Neurobehavioral_Manifestations</m> @DISEASE_MESH:D019954 @@@neurobehavioral alterations@@@ in rats", "citations": {"NLM": "Ebokaiwe AP, Okori S, Nwankwo JO, Ejike CECC, Osawe SO. Selenium nanoparticles and metformin ameliorate streptozotocin-instigated brain oxidative-inflammatory stress and neurobehavioral alterations in rats Naunyn Schmiedebergs Arch Pharmacol. 2021 Apr;394(4):591-602. PMID: 33064168", "BibTeX": "@article{33064168, title={Selenium nanoparticles and metformin ameliorate streptozotocin-instigated brain oxidative-inflammatory stress and neurobehavioral alterations in rats}, author={Ebokaiwe AP and Okori S and Nwankwo JO and Ejike CECC and Osawe SO}, journal={Naunyn Schmiedebergs Arch Pharmacol}, volume={394}, number={4}, pages={591-602}}"}}]}